Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt
We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging stu...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2007-12, Vol.13 (47), p.6439-6440 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6440 |
---|---|
container_issue | 47 |
container_start_page | 6439 |
container_title | World journal of gastroenterology : WJG |
container_volume | 13 |
creator | Giannarelli, Chiara De Giorgi, Antonio De Negri, Ferdinando Carmassi, Franco |
description | We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis. |
doi_str_mv | 10.3748/wjg.v13.i47.6439 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>26173623</cqvip_id><sourcerecordid>69075826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3369-6ce8328def8f91b3d92f055281b72d1168e0326561725ef22ebd7ed19e8a81ef3</originalsourceid><addsrcrecordid>eNpVkctv1DAQhy0EokvhzglZHLhl8SOxnQsSanlJlbjA2XKc8cYlsVPb2ar_Pa52xeM0h_nNNzP6EHpNyZ7LVr2_vz3sj5TvfSv3ouX9E7RjjPYNUy15inaUENn0nMkL9CLnW0IY5x17ji6oIooyLncIrsHGZYWQTYERrzGV2KzbvMRg0gOeHlZIpXZ9DNgHbLD1KU2xeItXUzyEgu99mXCZUlyGmH3G0Z0w1hzNjPO0hfISPXNmzvDqXC_Rz8-fflx9bW6-f_l29fGmsZyLvhEWFGdqBKdcTwc-9syRrmOKDpKNlAoFhDPRCSpZB44xGEYJI-1BGUXB8Uv04cRdt2GB0dbzkpn1mvxSv9HReP1_J_hJH-JRt4x0rZAV8O4MSPFug1z04rOFeTYB4pa16InsFBM1SE5Bm2LOCdyfJZToRze6utHVja5u9KObOvLm3-P-Dpxl1MDbM3OK4XDnw0EPxv5yfgbN6s9cVH-_AUtWmvA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69075826</pqid></control><display><type>article</type><title>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Giannarelli, Chiara ; De Giorgi, Antonio ; De Negri, Ferdinando ; Carmassi, Franco</creator><creatorcontrib>Giannarelli, Chiara ; De Giorgi, Antonio ; De Negri, Ferdinando ; Carmassi, Franco</creatorcontrib><description>We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v13.i47.6439</identifier><identifier>PMID: 18081237</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Aged ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive Agents - therapeutic use ; Case Report ; Diet, Sodium-Restricted ; Diuretics - therapeutic use ; Drug Therapy, Combination ; Dyspnea - etiology ; Edema - etiology ; Female ; Fibrinolytic Agents - therapeutic use ; Gastrointestinal Agents - therapeutic use ; Heparin, Low-Molecular-Weight - therapeutic use ; Humans ; Hypertension, Portal - complications ; Hypertension, Portal - drug therapy ; Hypertension, Portal - etiology ; Hypertension, Portal - physiopathology ; Hypertension, Pulmonary - complications ; Hypertension, Pulmonary - drug therapy ; Hypertension, Pulmonary - etiology ; Hypertension, Pulmonary - physiopathology ; Lactulose - therapeutic use ; Liver Cirrhosis - surgery ; Portal Pressure ; Portasystemic Shunt, Surgical - adverse effects ; Spironolactone - therapeutic use ; Treatment Outcome ; Vasodilator Agents - therapeutic use ; Venous Thrombosis - complications ; Venous Thrombosis - drug therapy ; Venous Thrombosis - etiology ; Venous Thrombosis - physiopathology ; 肝硬化 ; 血栓形成 ; 高血压</subject><ispartof>World journal of gastroenterology : WJG, 2007-12, Vol.13 (47), p.6439-6440</ispartof><rights>2007 Baishideng Publishing Group Inc. All rights reserved. 2007</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3369-6ce8328def8f91b3d92f055281b72d1168e0326561725ef22ebd7ed19e8a81ef3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205467/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205467/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18081237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giannarelli, Chiara</creatorcontrib><creatorcontrib>De Giorgi, Antonio</creatorcontrib><creatorcontrib>De Negri, Ferdinando</creatorcontrib><creatorcontrib>Carmassi, Franco</creatorcontrib><title>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.</description><subject>Aged</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Case Report</subject><subject>Diet, Sodium-Restricted</subject><subject>Diuretics - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Dyspnea - etiology</subject><subject>Edema - etiology</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Heparin, Low-Molecular-Weight - therapeutic use</subject><subject>Humans</subject><subject>Hypertension, Portal - complications</subject><subject>Hypertension, Portal - drug therapy</subject><subject>Hypertension, Portal - etiology</subject><subject>Hypertension, Portal - physiopathology</subject><subject>Hypertension, Pulmonary - complications</subject><subject>Hypertension, Pulmonary - drug therapy</subject><subject>Hypertension, Pulmonary - etiology</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Lactulose - therapeutic use</subject><subject>Liver Cirrhosis - surgery</subject><subject>Portal Pressure</subject><subject>Portasystemic Shunt, Surgical - adverse effects</subject><subject>Spironolactone - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Vasodilator Agents - therapeutic use</subject><subject>Venous Thrombosis - complications</subject><subject>Venous Thrombosis - drug therapy</subject><subject>Venous Thrombosis - etiology</subject><subject>Venous Thrombosis - physiopathology</subject><subject>肝硬化</subject><subject>血栓形成</subject><subject>高血压</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctv1DAQhy0EokvhzglZHLhl8SOxnQsSanlJlbjA2XKc8cYlsVPb2ar_Pa52xeM0h_nNNzP6EHpNyZ7LVr2_vz3sj5TvfSv3ouX9E7RjjPYNUy15inaUENn0nMkL9CLnW0IY5x17ji6oIooyLncIrsHGZYWQTYERrzGV2KzbvMRg0gOeHlZIpXZ9DNgHbLD1KU2xeItXUzyEgu99mXCZUlyGmH3G0Z0w1hzNjPO0hfISPXNmzvDqXC_Rz8-fflx9bW6-f_l29fGmsZyLvhEWFGdqBKdcTwc-9syRrmOKDpKNlAoFhDPRCSpZB44xGEYJI-1BGUXB8Uv04cRdt2GB0dbzkpn1mvxSv9HReP1_J_hJH-JRt4x0rZAV8O4MSPFug1z04rOFeTYB4pa16InsFBM1SE5Bm2LOCdyfJZToRze6utHVja5u9KObOvLm3-P-Dpxl1MDbM3OK4XDnw0EPxv5yfgbN6s9cVH-_AUtWmvA</recordid><startdate>20071221</startdate><enddate>20071221</enddate><creator>Giannarelli, Chiara</creator><creator>De Giorgi, Antonio</creator><creator>De Negri, Ferdinando</creator><creator>Carmassi, Franco</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20071221</creationdate><title>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</title><author>Giannarelli, Chiara ; De Giorgi, Antonio ; De Negri, Ferdinando ; Carmassi, Franco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3369-6ce8328def8f91b3d92f055281b72d1168e0326561725ef22ebd7ed19e8a81ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Case Report</topic><topic>Diet, Sodium-Restricted</topic><topic>Diuretics - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Dyspnea - etiology</topic><topic>Edema - etiology</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Heparin, Low-Molecular-Weight - therapeutic use</topic><topic>Humans</topic><topic>Hypertension, Portal - complications</topic><topic>Hypertension, Portal - drug therapy</topic><topic>Hypertension, Portal - etiology</topic><topic>Hypertension, Portal - physiopathology</topic><topic>Hypertension, Pulmonary - complications</topic><topic>Hypertension, Pulmonary - drug therapy</topic><topic>Hypertension, Pulmonary - etiology</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Lactulose - therapeutic use</topic><topic>Liver Cirrhosis - surgery</topic><topic>Portal Pressure</topic><topic>Portasystemic Shunt, Surgical - adverse effects</topic><topic>Spironolactone - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Vasodilator Agents - therapeutic use</topic><topic>Venous Thrombosis - complications</topic><topic>Venous Thrombosis - drug therapy</topic><topic>Venous Thrombosis - etiology</topic><topic>Venous Thrombosis - physiopathology</topic><topic>肝硬化</topic><topic>血栓形成</topic><topic>高血压</topic><toplevel>online_resources</toplevel><creatorcontrib>Giannarelli, Chiara</creatorcontrib><creatorcontrib>De Giorgi, Antonio</creatorcontrib><creatorcontrib>De Negri, Ferdinando</creatorcontrib><creatorcontrib>Carmassi, Franco</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giannarelli, Chiara</au><au>De Giorgi, Antonio</au><au>De Negri, Ferdinando</au><au>Carmassi, Franco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2007-12-21</date><risdate>2007</risdate><volume>13</volume><issue>47</issue><spage>6439</spage><epage>6440</epage><pages>6439-6440</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>We report a case of decompensated porto-pulmonary hypertension closely associated with the development of intra-portocaval shunt thrombosis. A woman with Laennec's cirrhosis was hospitalized because of severe dyspnea and edema. She underwent surgical portocaval anastomosis ten years ago. Imaging studies showed massive intra-shunt thrombosis, portal hypertension, ascites, pleuro-pericardial effusions and enlargement of right cardiac cavities. Cardiac catheterization allowed to rule out coronary and left-sided heart abnormalities and led to the diagnosis of pre-capillary pulmonary hypertension. Antithrombotic treatment with low molecular weight heparin was instituted. The management also included ACE inhibitors, spironolactone, low-salt diet and lactulose. The patient was discharged and three months later we observed the disappearance of edema, ascites and pleuro-pericardial effusions, a marked body weight reduction and improved dyspnea and liver function tests. A possible link between the development of intra-shunt thrombosis and clinical decompensation in our patient was hypothesized. In fact, it has been demonstrated that the increased portal pressure, caused by occlusion of portosystemic shunt, reduces renal plasma flow and increases systemic endothelin-1 concentration. In our patient the disappearance of edematous state and improved dyspnea observed after recanalization of the shunt strongly support this hypothesis.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>18081237</pmid><doi>10.3748/wjg.v13.i47.6439</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2007-12, Vol.13 (47), p.6439-6440 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4205467 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection |
subjects | Aged Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Case Report Diet, Sodium-Restricted Diuretics - therapeutic use Drug Therapy, Combination Dyspnea - etiology Edema - etiology Female Fibrinolytic Agents - therapeutic use Gastrointestinal Agents - therapeutic use Heparin, Low-Molecular-Weight - therapeutic use Humans Hypertension, Portal - complications Hypertension, Portal - drug therapy Hypertension, Portal - etiology Hypertension, Portal - physiopathology Hypertension, Pulmonary - complications Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - etiology Hypertension, Pulmonary - physiopathology Lactulose - therapeutic use Liver Cirrhosis - surgery Portal Pressure Portasystemic Shunt, Surgical - adverse effects Spironolactone - therapeutic use Treatment Outcome Vasodilator Agents - therapeutic use Venous Thrombosis - complications Venous Thrombosis - drug therapy Venous Thrombosis - etiology Venous Thrombosis - physiopathology 肝硬化 血栓形成 高血压 |
title | Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A20%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decompensated%20porto-pulmonary%20hypertension%20in%20a%20cirrhotic%20patient%20with%20thrombosis%20of%20portocaval%20shunt&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Giannarelli,%20Chiara&rft.date=2007-12-21&rft.volume=13&rft.issue=47&rft.spage=6439&rft.epage=6440&rft.pages=6439-6440&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v13.i47.6439&rft_dat=%3Cproquest_pubme%3E69075826%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69075826&rft_id=info:pmid/18081237&rft_cqvip_id=26173623&rfr_iscdi=true |